IHC/IF accessory reagents

IHC/IF accessory reagents

Descrizione	Azione
Wilms' Tumor 1(WT1) is a tumor suppressor gene, which is related to nephroblastoma. At the same time, it can be used to mark malignant mesothelioma and ovarian serous tumor, while uterine serous cancer is negative. Ewing's sarcoma and primitive neuroectodermal tumor are also negative, Wilms' Tumor 1(WT1) can be used for differential judging of some small round cell tumors. WT1 Monoclonal Antibody Codice: ELAB6533-M_1mL Confezionamento: 1mL	Dettagli
Wilms' Tumor 1(WT1) is a tumor suppressor gene, which is related to nephroblastoma. At the same time, it can be used to mark malignant mesothelioma and ovarian serous tumor, while uterine serous cancer is negative. Ewing's sarcoma and primitive neuroectodermal tumor are also negative, Wilms' Tumor 1(WT1) can be used for differential judging of some small round cell tumors. WT1 Monoclonal Antibody Codice: ELAB6533-M_0.1ml Confezionamento: 0.1ml	Dettagli
Wilms' Tumor 1(WT1) is a tumor suppressor gene, which is related to nephroblastoma. At the same time, it can be used to mark malignant mesothelioma and ovarian serous tumor, while uterine serous cancer is negative. Ewing's sarcoma and primitive neuroectodermal tumor are also negative, Wilms' Tumor 1(WT1) can be used for differential judging of some small round cell tumors. WT1 Monoclonal Antibody Codice: ELAB6533-M_0.2ml Confezionamento: 0.2ml	Dettagli
Wilms' Tumor 1(WT1) is a tumor suppressor gene, which is related to nephroblastoma. At the same time, it can be used to mark malignant mesothelioma and ovarian serous tumor, while uterine serous cancer is negative. Ewing's sarcoma and primitive neuroectodermal tumor are also negative, Wilms' Tumor 1(WT1) can be used for differential judging of some small round cell tumors. WT1 Monoclonal Antibody Codice: PA6533_3ml Confezionamento: 3ml	Dettagli
Wilms' Tumor 1(WT1) is a tumor suppressor gene, which is related to nephroblastoma. At the same time, it can be used to mark malignant mesothelioma and ovarian serous tumor, while uterine serous cancer is negative. Ewing's sarcoma and primitive neuroectodermal tumor are also negative, Wilms' Tumor 1(WT1) can be used for differential judging of some small round cell tumors. WT1 Monoclonal Antibody Codice: PA6533_6mL Confezionamento: 6mL	Dettagli
Wilms' Tumor 1(WT1) is a tumor suppressor gene, which is related to nephroblastoma. At the same time, it can be used to mark malignant mesothelioma and ovarian serous tumor, while uterine serous cancer is negative. Ewing's sarcoma and primitive neuroectodermal tumor are also negative, Wilms' Tumor 1(WT1) can be used for differential judging of some small round cell tumors. WT1 Monoclonal Antibody Codice: PA6533_1.5ml Confezionamento: 1.5ml	Dettagli
ZAP-70 is a kind of protein kinase, which is expressed in T cells and NK cells and participates in the activation of T cell receptor. The mutation of this gene will lead to severe compound immunodeficiency syndrome (SCID). The antigen is also related to the mutation of LG heavy chain gene in patients with chronic lymphocytic leukemia (CLL), disease progression and prognosis. Therefore, the expression of ZAP-70 can be used for the prognosis of CLL. ZAP-70 Monoclonal Antibody Codice: ELAB6657-M_0.2ml Confezionamento: 0.2ml	Dettagli
ZAP-70 is a kind of protein kinase, which is expressed in T cells and NK cells and participates in the activation of T cell receptor. The mutation of this gene will lead to severe compound immunodeficiency syndrome (SCID). The antigen is also related to the mutation of LG heavy chain gene in patients with chronic lymphocytic leukemia (CLL), disease progression and prognosis. Therefore, the expression of ZAP-70 can be used for the prognosis of CLL. ZAP-70 Monoclonal Antibody Codice: PA6657_1.5ml Confezionamento: 1.5ml	Dettagli
ZAP-70 is a kind of protein kinase, which is expressed in T cells and NK cells and participates in the activation of T cell receptor. The mutation of this gene will lead to severe compound immunodeficiency syndrome (SCID). The antigen is also related to the mutation of LG heavy chain gene in patients with chronic lymphocytic leukemia (CLL), disease progression and prognosis. Therefore, the expression of ZAP-70 can be used for the prognosis of CLL. ZAP-70 Monoclonal Antibody Codice: PA6657_3ml Confezionamento: 3ml	Dettagli
ZAP-70 is a kind of protein kinase, which is expressed in T cells and NK cells and participates in the activation of T cell receptor. The mutation of this gene will lead to severe compound immunodeficiency syndrome (SCID). The antigen is also related to the mutation of LG heavy chain gene in patients with chronic lymphocytic leukemia (CLL), disease progression and prognosis. Therefore, the expression of ZAP-70 can be used for the prognosis of CLL. ZAP-70 Monoclonal Antibody Codice: PA6657_6mL Confezionamento: 6mL	Dettagli
ZAP-70 is a kind of protein kinase, which is expressed in T cells and NK cells and participates in the activation of T cell receptor. The mutation of this gene will lead to severe compound immunodeficiency syndrome (SCID). The antigen is also related to the mutation of LG heavy chain gene in patients with chronic lymphocytic leukemia (CLL), disease progression and prognosis. Therefore, the expression of ZAP-70 can be used for the prognosis of CLL. ZAP-70 Monoclonal Antibody Codice: ELAB6657-M_1mL Confezionamento: 1mL	Dettagli
ZAP-70 is a kind of protein kinase, which is expressed in T cells and NK cells and participates in the activation of T cell receptor. The mutation of this gene will lead to severe compound immunodeficiency syndrome (SCID). The antigen is also related to the mutation of LG heavy chain gene in patients with chronic lymphocytic leukemia (CLL), disease progression and prognosis. Therefore, the expression of ZAP-70 can be used for the prognosis of CLL. ZAP-70 Monoclonal Antibody Codice: ELAB6657-M_0.1ml Confezionamento: 0.1ml	Dettagli

1…111 112 113114

Marca

Confezionamento

Conservazione

Specie target

Host

Clonalità

Clone

Coniugazione

Tipo di saggio

Data di scadenza

Applicazione

Reset

2025 TEMA Ricerca - All Rights Reserved.